Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03010917 · ClinicalTrials.gov registry record · Phase 1
Fish Oil vs. Placebo on Subjective Effects of Alcohol
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT03010917 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 17 participants.
The verdict
NCT03010917, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
This project represents a first step in examining the potential use of fish oil for the treatment of alcohol use disorder (AUD). The investigators will be testing for attenuation of alcohol-induced sedative and stimulant effects, as well as cognitive effects and cerebellar effects in healthy social drinkers.
Interventions
- DRUG Fish Oil with ethanol and placebo ethanol infusions
- DRUG Placebo with ethanol and placebo ethanol infusions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2017-03-02 |
| Est. Completion | 2021-09-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03010917
The ClinicalTrials.gov registry entry for NCT03010917 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fish Oil with ethanol and placebo ethanol infusions is the first listed.
NCT03010917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03010917 about?
NCT03010917 is a clinical study titled "Fish Oil vs. Placebo on Subjective Effects of Alcohol". This project represents a first step in examining the potential use of fish oil for the treatment of alcohol use disorder (AUD). The investigators will be testing for attenuation of alcohol-induced sedative and stimulant effects, as well as cognitive effects and cerebellar effects in healthy social ...
What is the current status of trial NCT03010917?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2017-03-02. Estimated completion is 2021-09-08.
What interventions are being tested in trial NCT03010917?
The interventions under investigation include: Fish Oil with ethanol and placebo ethanol infusions (DRUG), Placebo with ethanol and placebo ethanol infusions (DRUG).
Who is sponsoring clinical trial NCT03010917?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.